Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9:400–414

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson GSF, Ballester-Beltran J, Giotopoulos G, Guerrero JA, Surget S, Williamson JC, So T, Bloxham D, Aubareda A, Asby R et al (2022) Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Blood 139:2471–2482

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avouac J, Pezet S, Vandebeuque E, Orvain C, Gonzalez V, Marin G, Mouterde G, Daien C, Allanore Y (2021) Semaphorins: from angiogenesis to inflammation in rheumatoid arthritis. Arthritis Rheumatol 73:1579–1588

Article  CAS  PubMed  Google Scholar 

Boese AC, Kang S (2021) Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol 42:101870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17:395–417

Article  PubMed  PubMed Central  Google Scholar 

Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J et al (2013) Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501:252–256

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiNardo CD, Erba HP, Freeman SD, Wei AH (2023) Acute myeloid leukaemia. Lancet 401:2073–2086

Article  CAS  PubMed  Google Scholar 

DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM et al (2019) Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood 133:7–17

Article  CAS  PubMed  Google Scholar 

Forsberg M, Konopleva M (2024) AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci 45:430–448

Article  CAS  PubMed  Google Scholar 

Gu H, Chen C, Hou ZS, He XD, Xie S, Ni J, Qian C, Cheng X, Jiang T, Yang C et al (2024) PI3Kgamma maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. Blood 143:1965–1979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou S, Liu J, Zhu Y (2025) Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig 1:100007

Article  Google Scholar 

Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D et al (2015) Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell 57:860–872

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito D, Kumanogoh A (2016) The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems. Cell Adh Migr 10:692–699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ et al (2016) Acute myeloid leukaemia. Nat Rev Dis Primers 2:V

Article  Google Scholar 

Kotulova J, Badurova K, Chyra Z, Sevcikova S, Garbova N, Jelinek T, Hajek R, Hrdinka M (2025) Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential. Biomark Res 13:92

Article  PubMed  PubMed Central  Google Scholar 

Kumanogoh A, Marukawa S, Suzuki K, Takegahara N, Watanabe C, Ch’ng E, Ishida I, Fujimura H, Sakoda S, Yoshida K et al (2002) Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419:629–633

Article  CAS  PubMed  Google Scholar 

Liu H (2021) Emerging agents and regimens for AML. J Hematol Oncol 14:49

Article  PubMed  PubMed Central  Google Scholar 

Liu L, Yang L, Liu X, Liu M, Liu J, Feng X, Nie Z, Luo J (2022) SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling. J Transl Med 20:304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Tan W, Wang W, Feng T, Wang C, Wang L, Zhou W (2023) SEMA4A promotes prostate cancer invasion: Involvement of tumor microenvironment. J Cancer 14:2633–2643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng F, Li H, Wang Y, Zheng Z, Chen YJCI (2025) The mechanism of AKT activation in cancer. Cell Investig 1(4):100046

Article  Google Scholar 

Moyer A, Tanaka K, Cheng EH (2025) Apoptosis in cancer biology and therapy. Annu Rev Pathol Mech Dis 20:303–328

Article  CAS  Google Scholar 

Naito Y, Koyama S, Masuhiro K, Hirai T, Uenami T, Inoue T, Osa A, Machiyama H, Watanabe G, Sax N et al (2023) Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8(+) T cell cytotoxicity and proliferation. Sci Adv 9:10

Article  Google Scholar 

Nwosu GO, Ross DM, Powell JA, Pitson SM (2024) Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death Dis 15:413

Article  PubMed  PubMed Central  Google Scholar 

Ong F, Kim K, Konopleva MY (2022) Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist 5:380–400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasterkamp RJ, Kolodkin AL (2003) Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 13:79–89

Article  CAS  PubMed  Google Scholar 

Rehman M, Tamagnone L (2013) Semaphorins in cancer: biological mechanisms and therapeutic approaches. Semin Cell Dev Biol 24:179–189

Article  CAS  PubMed  Google Scholar 

Rice DS, Huang W, Jones HA, Hansen G, Ye GL, Xu N, Wilson EA, Troughton K, Vaddi K, Newton RC et al (2004) Severe retinal degeneration associated with disruption of semaphorin 4A. Invest Ophthalmol vis Sci 45:2767–2777

Article  PubMed  Google Scholar 

Roberts AW, Wei AH, Huang DCS (2021) BCL2 and MCL1 inhibitors for hematologic malignancies. Blood 138:1120–1136

Article  CAS  PubMed  Google Scholar 

Schulz E, Klampfl P, Holzapfel S, Janecke AR, Ulz P, Renner W, Kashofer K, Nojima S, Leitner A, Zebisch A et al (2014) Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nat Commun 5:5191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh R, Letai A, Sarosiek K (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol 20:175–193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun T, Yang L, Kaur H, Pestel J, Looso M, Nolte H, Krasel C, Heil D, Krishnan RK, Santoni MJ et al (2017) A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. J Cell Biol 216:199–215

Article  CAS  PubMed